Log In
BCIQ
Print this Print this
 

Urolieve (PSD597)

  Manage Alerts
Collapse Summary General Information
Company Plethora Solutions Holdings plc
DescriptionProprietary formulation of lidocaine
Molecular Target Sodium channel
Mechanism of ActionNa channel blocker
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationCystitis
Indication DetailsTreat painful bladder syndrome (PBS) and interstitial cystitis (IC)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$789.0M

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

11/04/2015

$789.0M

0

0

Get a free BioCentury trial today